Uso de la anoscopia de alta resolución para la detección de displasia anal por papilomavirus en pacientes con enfermedad inflamatoria intestinal
DOI:
https://doi.org/10.22516/25007440.1048Palabras clave:
Virus del papiloma humano, Enfermedad inflamatoria intestinal, Displasia anal, Cáncer anal, Anoscopia de alta resoluciónResumen
Introducción: el carcinoma anal de células escamosas es raro, pero su incidencia y mortalidad han ido en aumento globalmente. El 90% de los casos están relacionados con la infección por el virus del papiloma humano (VPH)(1,2) y los pacientes con enfermedad inflamatoria intestinal (EII) tienen un mayor riesgo de infección por este virus; se ha identificado una incidencia de 5,5 por 100.000 pacientes en el grupo de EII frente a 1,8 en el grupo sin EII(3).
Metodología: se realizó un estudio descriptivo de serie de casos en el que se incluyó a 21 pacientes con EII, sin síntomas perianales, entre enero y julio de 2022 en el Instituto de Coloproctología de Medellín, a quienes se les realizó citología anal, genotipificación del VPH y anoscopia de alta resolución, previa explicación y aceptación del procedimiento. Si se encontraban lesiones, se realizaba tratamiento ablativo.
Resultados: el 23% de esta cohorte tenía lesiones escamosas de bajo grado, mientras que el 14,2% presentaba lesiones de alto grado con cambios de displasia al momento de la anoscopia. El 90,4% tenían genotipificación positiva para VPH, de los cuales el 76,1% eran de alto grado.
Conclusiones: nuestro estudio sugiere que esta serie de pacientes con EII se comporta como un grupo de alto riesgo para desarrollar lesiones premalignas en asociación con el VPH. La anoscopia de alta resolución es un método rentable, indoloro y asequible que, en manos expertas, puede impactar el diagnóstico y manejo de lesiones premalignas y disminuir la incidencia de cáncer anal en pacientes con EII.
Descargas
Referencias bibliográficas
Roberts JR, Siekas LL, Kaz AM. Anal intraepithelial neoplasia: A review of diagnosis and management. World J Gastrointest Oncol. 2017;9(02):50-61. https://doi.org/10.4251/wjgo.v9.i2.50
Savio MC, Svoboda Baldin RK, Nóbrega NL, Nicollelli GM, Brenner AS, Borges da Rocha P, et al. Prevalence of Anal Intraepithelial Lesions in Patients with Inflammatory Bowel Disease. J Coloproctol. 2021;41(3):222-227. https://doi.org/10.1055/s-0041-1730425
Vuitton L, Jacquin E, Parmentier AL, Crochet E, Fein F, Dupont-Gossart AC, et al. High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn’s Disease. Clin Gastroenterol Hepatol. 2018;16(11):1768-1776.e5. https://doi.org/10.1016/j.cgh.2018.03.008
Palefsky JM. Practising high-resolution anoscopy. Sex Health. 2012;9(6):580-6. https://doi.org/10.1071/SH12045
Sendagorta E, Herranz P, Guadalajara H, Bernardino JI, Viguer JM, Beato MJ, et al. Prevalence of abnormal anal cytology and high-grade squamous intraepithelial lesions among a cohort of HIV-infected men who have sex with men. Dis Colon Rectum. 2014;57(04):475-481. https://doi.org/10.1097/DCR.0000000000000095
Oon SF, Winter DC. Perianal condylomas, anal squamous intraepithelial neoplasms and screening: a review of the literature. J Med Screen. 2010;17(01):44-49. https://doi.org/10.1258/jms.2009.009058
Cranston RD, Regueiro M, Hashash J, Baker JR, Richardson-Harman N, Janocko L, et al. A pilot study of the prevalence of anal human papillomavirus and dysplasia in a cohort of patients with IBD. Dis Colon Rectum. 2017;60(12):1307-1313. https://doi.org/10.1097/DCR.0000000000000878
Richel O, Hallensleben ND, Kreuter A, van Noesel CJ, Prins JM, de Vries HJ. High-resolution anoscopy: clinical features of anal intraepithelial neoplasia in HIV-positive men. Dis Colon Rectum. 2013;56(11):1237-42. https://doi.org/10.1097/DCR.0b013e3182a53568
Camus M, Lesage AC, Fléjou JF, Hoyeau N, Atienza P, Etienney I. Which lesions should be biopsied during high-resolution anoscopy? Prospective descriptive study of simple morphological criteria. J Low Genit Tract Dis. 2015;19(2):156-160. https://doi.org/10.1097/LGT.0000000000000064
Limoges-Gonzalez M, Al-Juburi A. Anal Intraepithelial Neoplasia. J Clin Gastroenterol. 2017;51(3):203-207. https://doi.org/10.1097/MCG.0000000000000721
Ruel J, Ko HM, Roda G, Patil N, Zhang D, Jharap B, et al. Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal Disease. Clin Transl Gastroenterol. 2016;7(3):e148. https://doi.org/10.1038/ctg.2016.8
Poggio JL. Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal. Clin Colon Rectal Surg. 2011;24(3):177-192. https://doi.org/10.1055/s-0031-1286002
Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Ning L, et al. Acquisition of anal human papillomavirus (HPV) infection in women:the Hawaii HPV cohort study. J Infect Dis. 2008;197(7):957-966. https://doi.org/10.1086/529207
Shvetsozv YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu X, Ning L, et al. Duration and clearance of anal human papillomavirus (HPV) infection among women: The Hawaii HPV cohort study. Clin Infect Dis. 2009;48(5):536-546. https://doi.org/10.1086/596758
Nyitray AG, Carvalho RJ, Baggio ML, Lu B, Smith D, Abrahamsen M, et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis. 2011;203(1):49-57. https://doi.org/10.1093/infdis/jiq021
Steele SR, Varma MG, Melton GB, et al. Practice parameters for anal squamous neoplasms. Dis Colon Rectum. 2012;55(7):735-49. https://doi.org/10.1097/DCR.0b013e318255815e
Shah SB, Pickham D, Araya H, Kamal A, Pineda CE, Ghole S, et al. Prevalence of anal dysplasia in patients with inflammatory bowel disease. Clin Gastro Hepatol. 2015;13(11):1955-1961. https://doi.org/10.1016/j.cgh.2015.05.031
Messick CA, Rodriguez-Bigas MA. Anal Dysplasia. Surg Oncol Clin N Am. 2017;26(1):33-43. https://doi.org/10.1016/j.soc.2016.07.005
Slesser AA, Bhangu A, Bower M, Goldin R, Tekkis PP. A systematic review of anal squamous cell carcinoma in inflammatory bowel disease. Surg Oncol. 2013;22(4):230-7. https://doi.org/10.1016/j.suronc.2013.08.002
Bhatia J, Bratcher J, Korelitz B, Vakher K, Mannor S, Shevchuk M, et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol. 2006;12(38):6167-6171. https://doi.org/10.3748/wjg.v12.i38.6167
Wong AK, Chan RC, Aggarwal N, Singh MK, Nichols WS, Bose S. Human papillomavirus genotypes in anal intraepithelial neoplasia and anal carcinoma as detected in tissue biopsies. Mod Pathol An Official J United States Can Acad Pathol Inc 2010;23(1):144e50. https://doi.org/10.1038/modpathol.2009.143
Vuitton L, Jacquin E, Parmentier AL, Crochet E, Fein F, Dupont-Gossart AC, et al. High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn’s Disease. Clin Gastroenterol Hepatol. 2018;16(11):1768-1776.e5. https://doi.org/10.1016/j.cgh.2018.03.008
Abramowitz L, Mathieu N, Roudot-Thoraval F, Lemarchand N, Bauer P, Hennequin C, et al. Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients. Aliment Pharmacol Ther. 2009;30(4):414-21. https://doi.org/10.1111/j.1365-2036.2009.04026.x
Allegretti JR, Barnes EL, Cameron A. Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis. Inflamm Bowel Dis 2015;21(5):1089-97. https://doi.org/10.1097/MIB.0000000000000338
Hutfless S, Fireman B, Kane S, Herrinton LJ. Screening differences and risk of cervical cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2008;28(5):598-605. https://doi.org/10.1111/j.1365-2036.2008.03766.x
Guzela VR, Sobrado Junior CW, Nadal SR, Villa LL, Mota GR, Gonçalves AP, et al. Is there a higher frequency of anal dysplasia and infection by human papillomavirus in Crohn’s disease patients? Braz J Med Biol Res. 2022;55:e12141. https://doi.org/10.1590/1414-431x2022e12141
Gaiotti D, Chung J, Iglesias M, Nees M, Baker PD, Evans CH, et al. Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway. Mol Carcinog. 2000;27(2):97-109. https://doi.org/10.1002/(sici)1098-2744(200002)27:2<97::aid-mc5>3.0.co;2-v
Idriss HT, Naismith JH. TNFα and the TNF receptor superfamily: Structure-function relationship(s). Microsc Res Tech. 2000;50(3):184-95. https://doi.org/10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H
Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25(3):409-16. https://doi.org/10.1007/s10555-006-9005-3
Handisurya A, Lázár S, Papay P, Primas C, Haitel A, Horvat R, et al. Anogenital human papillomavirus prevalence is unaffected by therapeutic tumour necrosis factor-alpha inhibition. Acta Derm Venereol. 2016;96(4):494-498. https://doi.org/10.2340/00015555-2298
Ram A, Noël JC, Marmol V, Benhadou F. Occurrence of an invasive cervical epidermoid carcinoma in a patient receiving TNF-α blocking therapy for hidradenitis suppurativa. JAAD Case Reports. 2018;4(9):857-859. https://doi.org/10.1016/j.jdcr.2018.06.014
Khodabandehlou N, Mostafaei S, Etemadi A, Ghasemi A, Payandeh M, Hadifar S, et al. Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins. BMC Cancer. 2019;19(1):61. https://doi.org/10.1186/s12885-019-5286-0
Ali KS, Ali HY, Jubrael JM. Concentration levels of IL-10 and TNFα cytokines in patients with human papilloma virus (HPV) DNA and DNA cervical lesions. J Immunotoxicol. 2012;9(2):168-72. https://doi.org/10.3109/1547691X.2011.642419
Jin L, Sturgis EM, Zhang J, Huang Z, Song X, Li C, et al. Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma. Mol Cancer. 2013;12:80. https://doi.org/10.1186/1476-4598-12-80
Wadström H, Frisell T, Sparén P, Askling J; ARTIS study group. Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden. Ann Rheum Dis. 2016;75(7):1272-8. https://doi.org/10.1136/annrheumdis-2015-208263
Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103(3):631-636. https://doi.org/10.1111/j.1572-0241.2007.01582.x
Magro F, Peyrin-Biroulet L, Sokol H, Aldeger X, Costa A, Higgins PD, et al. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III). J Crohns Colitis. 2014;8(1):31-44. https://doi.org/10.1016/j.crohns.2013.04.006
Beaugerie L. Inflammatory bowel disease therapies and cancer risk: where are we and where are we going? Gut. 2012;61(4):476-483. https://doi.org/10.1136/gutjnl-2011-301133
Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, et al. Serious infections and mortality in association with therapies for Crohn›s disease: TREAT registry. Clin Gastroenterol Hepatol. 2006;4(5):621-630. https://doi.org/10.1016/j.cgh.2006.03.002
Colombel J, Prantera C, Rutgeerts PJ, Panes J, Fleig WE, D›Haens G, et al. No new safety signals identified in Crohn›s disease patients treated with infliximab in an interim review of the ENCORE registry. Gastroenterology. 2008;134:A-472. https://doi.org/10.1016/S0016-5085(08)62209-X
Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D›Haens G, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009;3(2):47-91. https://doi.org/10.1016/j.crohns.2009.02.010
Gaidos JKJ, Bickston SJ. HPV infection and vaccination in patients with inflammatory bowel disease. Pract Gastroenterol. 2012;36(10):27-31.
Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300-304.
Panther LA, Wagner K, Proper J, Fugelso DK, Chatis PA, Weeden W, et al. High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis. 2004;38(10):1490-1492. https://doi.org/10.1086/383574
Camus M, Lesage AC, Fléjou JF, Hoyeau N, Atienza P, Etienney I. Which lesions should be biopsied during high-resolution anoscopy? Prospective descriptive study of simple morphological criteria. J Low Genit Tract Dis. 2015;19(2):156-160. https://doi.org/10.1097/LGT.0000000000000064
Albuquerque A. High-resolution anoscopy: Unchartered territory for gastroenterologists? World J Gastrointest Endosc. 2015;7(13):1083-1087. https://doi.org/10.4253/wjge.v7.i13.1083
Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8(6):443-68. https://doi.org/10.1016/j.crohns.2013.12.013
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Revista colombiana de Gastroenterología
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
